Baseline clinical characteristics
| Characteristics | Any Recanalization | Complete Recanalization | ||||
|---|---|---|---|---|---|---|
| Yes (66) | No (30) | P | Yes (25) | No (30) | P | |
| Age, y | 66.7 ± 12.8 | 69.9 ± 9.5 | .22 | 67.1 ± 13 | 69.9 ± 9.5 | .37 |
| Sex, male | 33 (50%) | 14 (46%) | .76 | 13 (57%) | 14 (46%) | .48 |
| Race, white | 50 (76%) | 24 (80%) | .46 | 17 (74%) | 24 (80%) | .60 |
| Hypertension | 40 (63%) | 20 (64%) | .63 | 14 (60.9%) | 20 (64) | .66 |
| Diabetes | 20 (29.8%) | 9 (30%) | .94 | 9 (39.1%) | 9 (30%) | .49 |
| Prior aspirin | 13 (20.3%) | 4 (13.3%) | .57 | 5 (22.7%) | 4 (13.3%) | .38 |
| Baseline NIHSS (median, IQR) | 14 (8, 20) | 18 (9, 22) | .08 | 16 (9, 20) | 18 (9, 22) | .66 |
| SBP, mm Hg | 153 ± 28.2 | 160 ± 32.9 | .31 | 157 ± 31.7 | 160 ± 32.9 | .74 |
| Glucose, mg/dL | 146.9 ± 67.6 | 145.4 ± 65.1 | .90 | 151.1 ± 15.3 | 145.4 ± 65.1 | .77 |
| Occluded vessel: | ||||||
| MCA | 49 (75.2%) | 17 (56.7%) | .09 | 20 (87%) | 17 (56.7%) | .02 |
| ICA | 10 (15.2%) | 11 (36.7%) | .02 | 2 (8.7%) | 11 (36.7%) | .02 |
| BA | 5 (7.6%) | 2 (6.7%) | .80 | 1 (4.4%) | 2 (6.7%) | .72 |
| IV/IA | 26 (39.4%) | 15 (50%) | .33 | 9 (36%) | 15 (50%) | .43 |
| Onset to therapy (min) | 208.9 ± 31 | 222.9 ± 92.2 | .47 | 172.6 ± 79.2 | 222.9 ± 92.2 | .04 |